In the ongoing legal showdown between Ripple Labs and the U.S. Securities and Exchange Commission (SEC)
Things are heating up as the discovery phase, focusing on “remedies” related to XRP sales, reaches a crucial point on February 20th. This phase bears substantial significance, holding the potential to unveil crucial information that might sway the court’s decision on appropriate actions against Ripple. Here’s a deep dive into what’s going on.
Understanding the Timeline
Despite expectations for today to be decisive in the Ripple vs SEC lawsuit, analyst Ashley Prosper in his X post, has clarified misconceptions about the case. Prosper emphasized that tomorrow is the extended deadline for remedies-related discovery, and the public won’t see any information from Ripple until the SEC files its brief on March 13.
Concerns Over SEC Conduct
Amidst the legal complexities, concerns about the SEC’s conduct emerge. Bill Morgan criticizes the agency for not correcting misleading statements to the court and condemns their motion to avoid accountability for attorneys’ alleged unethical behavior, calling for repercussions on professional misconduct grounds.
Racing Against Time
The SEC is eager to wrap up the case, looking to appeal the ruling on XRP sales and seeking penalties against Ripple for not registering XRP as a security. The clock is ticking, and last-minute filings could impact the schedule. The SEC has until March 13 to file, Ripple by April 12, and the SEC can respond by April 19. These recent developments highlight the intricate and contentious nature of the Ripple vs SEC lawsuit.
By
By
By
By
By
By